A 12-page Executive Summary offering summary highlights for 22 Accountable Care Organizations and ACO solutions companies regarding their successes during the most recent MSSP performance year.
The 10 Most Expensive U.S. Prescription Drugs
- Myalept (Amryt Pharma $71
- 306)
- Ravicti (Horizon Therapeutics $55
- 341)
- Mavenclad (EMD Serono
- Inc. $53
- 730)
- Actimmune (Horizon Therapeutics $52
- 777)
- Oxervate (Dompé $48
- 498)
- Takhzyro (Takeda $45
- 464)
- Daraprim (Vyera Pharmaceuticals $45
- 000)
- Juxtapid (Amryt Pharma $44
- 714)
- Cinryze (Takeda $44
- 141)
- Chenodal (Retrophin
- Inc $42
- 570)
Source: Source: GoodRx: The 20 Most Expensive Drugs in the U.S. - https://www.goodrx.com/blog/20-most-expensive-drugs-in-the-usa/